Comparison of Diagnostic Performance Between Standard Susceptibility Map‐Weighted Imaging and Susceptibility Map‐Weighted Imaging Reconstructed From Clinical SWI and Neuromelanin MRI in Early Parkinson's Disease
- 15 April 2026
- journal article
- neuro
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 64 (2) , 404-412
Abstract
Background: Susceptibility map‐weighted imaging (SMwI) provides high accuracy for early Parkinson's disease (ePD) by enhancing nigral hyperintensity. However, standard SMwI requires dedicated acquisition; reconstruction from routinely acquired sequences may offer a practical alternative. Purpose: To compare the diagnostic performance of standard SMwI with SWI‐ and neuromelanin (NM)‐driven SMwI for differentiating ePD from disease controls (DC). Study Type: Retrospective. Subjects: One hundred and eighty‐seven drug‐naïve ePD (age: 67.5 ± 9.4 years, 102 male) and 43 DC (age: 67.1 ± 9.2 years, 12 male). Field Strength/Sequence: 3 T, multi‐echo gradient‐echo (GRE) for standard SMwI; GRE‐based NM imaging: multi‐echo GRE for SWI. Assessment: Nigral hyperintensity was assessed by three neuroradiologists (4‐, 2‐, and 1‐year experience). Diagnostic performance was evaluated using clinical diagnosis for all subjects and PET for 106 subjects (98 ePD, 8 DC). PET‐based assessment included side‐based analyses accounting for PET laterality and patient‐based analyses regardless of direction. Statistical Tests: Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), accuracy and area under the curve (AUC) were assessed using clinical diagnosis as reference; sensitivity, specificity, and accuracy using PET. Significance was set at p < 0.05. Results: Using clinical diagnosis as reference, standard SMwI showed highest diagnostic performance (sensitivity 0.856; specificity 1.000; PPV 1.000; AUC 0.928). SWI‐driven SMwI maintained similar sensitivity ( p = 0.355) but showed significantly reduced specificity, PPV, accuracy, AUC. In the PET subgroup, side‐ and patient‐based analyses showed no differences in sensitivity ( p = 0.261, p = 0.670), specificity ( p = 1.000, p = 1.000) and accuracy ( p = 0.268, p = 0.695) between standard and SWI‐driven SMwI. Data Conclusion: SWI‐driven SMwI approached the diagnostic performance of standard SMwI with PET reference but showed inferior performance with clinical diagnosis, suggesting a fallback option when dedicated SMwI is unavailable. Evidence Level: 3. Technical Efficacy: Stage 1.Keywords
Funding Information
- Ministry of Health and Welfare (RS‐2026‐25468417)
- Ministry of Health and Welfare (RS‐2023‐00237618)
- Korea Health Industry Development Institute (RS‐2023‐00266288)
This publication has 41 references indexed in Scilit:
- Application of Neuromelanin MR Imaging in Parkinson DiseaseJournal of Magnetic Resonance Imaging, 2022
- Mild Parkinsonian Signs: A Systematic Review of Clinical, Imaging, and Pathological AssociationsMovement Disorders, 2021
- Screening for Early‐Stage Parkinson's Disease: Swallow Tail Sign on MRI Susceptibility Map‐Weighted Images Compared With PETJournal of Magnetic Resonance Imaging, 2020
- Importance of low diagnostic Accuracy for early Parkinson's diseaseMovement Disorders, 2018
- Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map‐weighted imaging (SMWI)Journal of Magnetic Resonance Imaging, 2016
- Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With 123I‐FP‐CIT SPECTMovement Disorders, 2016
- MDS clinical diagnostic criteria for Parkinson's diseaseMovement Disorders, 2015
- Dorsolateral nigral hyperintensity on 3.0T susceptibility‐weighted imaging in neurodegenerative ParkinsonismMovement Disorders, 2015
- Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing resultsMovement Disorders, 2008
- Sparse MRI: The application of compressed sensing for rapid MR imagingMagnetic Resonance in Medicine, 2007